Nuclear expression of XBP1s is correlated with breast cancer survival: a retrospective analysis based on tissue microarray

References

• Early Breast Cancer Trialists’ Collaborative GroupEffects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsLancet200536594721687171715894097
   PubMed Web of Science ®Google Scholar
• ForbesJFCuzickJBuzdarAHowellATobiasJSBaumMEffect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trialLancet Oncol200891455318083636
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists’ Collaborative GroupTamoxifen for early breast cancer: an overview of the randomised trialsLancet19983519114145114679605801
   PubMed Web of Science ®Google Scholar
• SiegelRMaJZouZJemalACancer statistics, 2014CA Cancer J Clin201464192924399786
   PubMed Web of Science ®Google Scholar
• PetoRDaviesCGodwinJComparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trialsLancet2012379981443244422152853
   PubMed Web of Science ®Google Scholar
• KrishnamurtiUSilvermanJFHER2 in breast cancer: a review and updateAdv Anat Pathol201421210010724508693
   PubMed Web of Science ®Google Scholar
• JensenEVJordanVCThe estrogen receptor: a model for molecular medicineClin Cancer Res2003961980198912796359
   PubMed Web of Science ®Google Scholar
• BackSHSchröderMLeeKZhangKKaufmanRJER stress signaling by regulated splicing: IRE1/HAC1/XBP1Methods200535439541615804613
   PubMed Web of Science ®Google Scholar
• Romero-RamirezLCaoHNelsonDXBP1 is essential for survival under hypoxic conditions and is required for tumor growthCancer Res200464175943594715342372
   PubMed Web of Science ®Google Scholar
• ShajahanANRigginsRBClarkeRThe role of X-box binding protein-1 in tumorigenicityDrug News Perspect200922524124619609461
   PubMedGoogle Scholar
• HetzCMartinonFRodriguezDGlimcherLHThe unfolded protein response: integrating stress signals through the stress sensor IRE1αPhysiol Rev20119141219124322013210
   PubMed Web of Science ®Google Scholar
• CaoSSKaufmanRJUnfolded protein responseCurr Biol20122216R622R62622917505
   PubMed Web of Science ®Google Scholar
• KoumenisCER stress, hypoxia tolerance and tumor progressionCurr Mol Med200661556916472113
   PubMed Web of Science ®Google Scholar
• MaurelMChevetETavernierJGerloSGetting RIDD of RNA: IRE1 in cell fate regulationTrends Biochem Sci201439524525424657016
   PubMed Web of Science ®Google Scholar
• BertucciFHoulgatteRBenzianeAGene expression profiling of primary breast carcinomas using arrays of candidate genesHum Mol Genet20009202981299111115842
   PubMed Web of Science ®Google Scholar
• GuZLeeRYSkaarTCAssociation of interferon regulatory factor-1, nucleophosmin, nuclear factor-κB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780)Cancer Res200262123428343712067985
   PubMedGoogle Scholar
• ScrivenPCoulsonSHainesRBalasubramanianSCrossSWyldLActivation and clinical significance of the unfolded protein response in breast cancerBr J Cancer2009101101692169819861963
   PubMedGoogle Scholar
• ChenXIliopoulosDZhangQXBP1 promotes triple-negative breast cancer by controlling the HIF1α pathwayNature2014508749410310724670641
   PubMed Web of Science ®Google Scholar
• LiHChenXGaoYWuJZengFSongFXBP1 induces snail expression to promote epithelial-to-mesenchymal transition and invasion of breast cancer cellsCell Signal2015271828925280941
   PubMedGoogle Scholar
• MingJRuanSWangMA novel chemical, STF-083010, reverses tamoxifen-related drug resistance in breast cancer by inhibiting IRE1/XBP1Oncotarget2015638406924070326517687
   PubMedGoogle Scholar
• YadavRKChaeSWKimHRChaeHJEndoplasmic reticulum stress and cancerJ Cancer Prev2014192758825337575
   PubMedGoogle Scholar
• YoshidaHER stress and diseasesFEBS J2007274363065817288551
   PubMed Web of Science ®Google Scholar
• UlianichLInsabatoLEndoplasmic reticulum stress in endometrial cancerFront Med (Lausanne)201415525593927
   PubMedGoogle Scholar
• HonmaYHaradaMNew therapeutic strategy for hepatocellular carcinoma by molecular targeting agents via inhibition of cellular stress defense mechanismsJ UOEH201436422923525501753
   PubMedGoogle Scholar
• ZhuJChenMChenNGlycyrrhetinic acid induces G1-phase cell cycle arrest in human nonsmall cell lung cancer cells through endoplasmic reticulum stress pathwayInt J Oncol201546398198825573651
   PubMedGoogle Scholar
• SovolyovaNHealySSamaliALogueSEStressed to death: mechanisms of ER stress-induced cell deathBiol Chem2014395111324002662
   PubMed Web of Science ®Google Scholar
• WangMKaufmanRJThe impact of the endoplasmic reticulum protein-folding environment on cancer developmentNat Rev Cancer201414958159725145482
   PubMed Web of Science ®Google Scholar
• KoongACChauhanVRomero-RamirezLTargeting XBP-1 as a novel anti-cancer strategyCancer Biol Ther20065775675916861911
   PubMed Web of Science ®Google Scholar
• ShudaMKondohNImazekiNActivation of the ATF6, XBP1 and GRP78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesisJ Hepatol200338560561412713871
   PubMed Web of Science ®Google Scholar
• ManieSNLebeauJChevetECellular mechanisms of endoplasmic reticulum stress signaling in health and disease – 3: orchestrating the unfolded protein response in oncogenesis – an updateAm J Physiol Cell Physiol201430710C901C90725186011
   PubMedGoogle Scholar
• VandewynckelYPLaukensDGeertsAThe paradox of the unfolded protein response in cancerAnticancer Res201333114683469424222102
   PubMed Web of Science ®Google Scholar
• WangWAGroenendykJMichalakMEndoplasmic reticulum stress associated responses in cancerBiochim Biophys Acta20141843102143214924440276
   PubMedGoogle Scholar
• PetrelliFBarniSRole of HER2-neu as a prognostic factor for survival and relapse in pT1a-bN0M0 breast cancer: a systematic review of the literature with a pooled-analysisMed Oncol20122942586259322415399
   PubMedGoogle Scholar
• HarrisHAKatzenellenbogenJAKatzenellenbogenBSCharacterization of the biological roles of the estrogen receptors, ERα and ERβ, in estrogen target tissues in vivo through the use of an ERα-selective ligandEndocrinology2002143114172417712399409
   PubMed Web of Science ®Google Scholar
• SáSIPereiraPAMalikovVMadeiraMDRole of estrogen receptor α and β in the induction of progesterone receptors in hypothalamic ventromedial neuronsNeuroscience201323815916723485817
   PubMedGoogle Scholar
• HuberKECareyLAWazerDEBreast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapySemin Radiat Oncol200919420421019732684
   PubMed Web of Science ®Google Scholar
• OmlinAAmichettiMAzriaDBoost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer NetworkLancet Oncol20067865265616887482
   PubMedGoogle Scholar
• ProvenzanoEHopperJLGilesGGMarrGVenterDJArmesJEBiological markers that predict clinical recurrence in ductal carcinoma in situ of the breastEur J Cancer200339562263012628841
   PubMedGoogle Scholar
• ZhangYGaoHGaoWThe volume and duration of wound drainage are independent prognostic factors for breast cancerTumor Biol201435435633568
   PubMedGoogle Scholar
• DingLYanJZhuJLigand-independent activation of estrogen receptor α by XBP-1Nucleic Acids Res200331185266527412954762
   PubMedGoogle Scholar
• FangYYanJDingLXBP-1 increases ERα transcriptional activity through regulation of large-scale chromatin unfoldingBiochem Biophys Res Commun2004323126927415351732
   PubMedGoogle Scholar
• AndresSAWittliffJLCo-expression of genes with estrogen receptor-α and progesterone receptor in human breast carcinoma tissueHorm Mol Biol Clin Investig2012121377390
   PubMedGoogle Scholar